Read More Pharma Industry News Why GILD stock sentiment may depend on more than one positive Phase 3 liver disease result Find out why GILD stock sentiment may need more than positive Livdelzi data as investors weigh Gilead’s liver disease growth strategy. bySoujanya RaviJune 5, 2026